@PeterDLROW @C7RKY @legalaware @DocMartin68 #bigpharma are an interesting case, where commercial interests are a determinant of science
-
-
Replying to @PublicHealthSte
@PublicHealthSte@PeterDLROW@legalaware@DocMartin68 Do think we permitted the unacceptable in big pharma model. Science plays 2nd fiddle +1 reply 0 retweets 0 likes -
Replying to @C7RKY
@PublicHealthSte@PeterDLROW@legalaware@DocMartin68 can't help but feel 'cures' are likely v unpopular w/ shareholders in such biz models1 reply 0 retweets 0 likes -
Replying to @C7RKY
@C7RKY@PeterDLROW@legalaware@DocMartin68 I assume cost-benefit ratios are estimated at some point in the decision-making process?1 reply 0 retweets 0 likes -
Replying to @PublicHealthSte
@PublicHealthSte@PeterDLROW@legalaware@DocMartin68 Sounds like a reasonable assumption to me...1 reply 0 retweets 0 likes -
Replying to @C7RKY
@C7RKY@PeterDLROW@legalaware@DocMartin68 Markets are indeed a strange mediator of human productivity, dont believe the hype.1 reply 0 retweets 0 likes
@PublicHealthSte @PeterDLROW @legalaware @DocMartin68 I accept very little on face value alone these days tbh. :)
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.